# Enrico Vanni

> Enrico Vanni is a startup investor at Novartis. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Novartis](https://shizune.co/investors/profile/novartis)
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/enrico-vanni-0717923a

Enrico Vanni is a startup investor at Novartis. Enrico Vanni has been a member of the Board of Directorssince 2011. He qualifies as an independent Non-Executive Director.He serves as Vice Chairman of the Board of Directors andChairman of the Compensation Committee. He is also a member ofthe Audit and Compliance Committee and the Research &Development Committee.Since hisretirement as director of McKinsey & Company in 2007,Vanni has been an independent consultant. He is currently amember of several boards of directors in industries from healthcareto private banking, including Advanced Oncotherapy plc in England,and several non-listed companies including Lombard Odier SA,Banque Privée BCP (Suisse) SA, Eclosion2, Jan-Autos Holding SA,and Denzler & Partners SA, all based in Switzerland.Vanni holds an engineering degree in chemistry from theFederal Polytechnic School of Lausanne, Switzerland, a Ph.D. inchemistry from the University of Lausanne; as well as a Master ofBusiness Administration from INSEAD in Fontainebleau, France. Hebegan his career as a research engineer at International BusinessMachines Corp. in California, United States, and joined McKinsey &Company in Zurich in 1980. He managed the Geneva office forMcKinsey from 1988 to 2004, and consulted for companies in thepharmaceutical, consumer and finance sectors. He led McKinsey’sEuropean pharmaceutical practice and served as a member of thefirm’s partner review committee prior to his retirement in 2007. Asan independent consultant, Vanni has continued to supportleaders of pharmaceutical and biotechnology companies on corestrategic challenges facing the healthcare industry.

## About Novartis

VC Fund · Basel, Switzerland

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

5 contacts available at Novartis.

| Name | Title | Profile |
| --- | --- | --- |
| Enrico Vanni | Board of Directors | https://shizune.co/investors/profile/enrico-vanni |
| Iya Khalil | Global Head of the AI Innovation Center at Novartis | https://shizune.co/investors/profile/iya-khalil |
| José Marcilla | Senior Vice President Head of Southern, Eastern, Russia & Central Europe | https://shizune.co/investors/profile/jos%C3%A9-marcilla |
| Justin Rauschkolb | Associate Director, Digital Marketing - HCP Media | https://shizune.co/investors/profile/justin-rauschkolb |
| Rana Lonnen | Managing Director | https://shizune.co/investors/profile/rana-lonnen |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co